Early change in the clearance of pembrolizumab reflects the survival and therapeutic response: A population pharmacokinetic analysis in real-world non-small cell lung cancer patients
Mayu Ohuchi, Shigehiro Yagishita, Hitomi Jo, Kazumasa Akagi, Ryoko Inaba Higashiyama, Ken Masuda, Yuki Shinno, Yusuke Okuma, Tatsuya Yoshida, Yasushi Goto, Hidehito Horinouchi, Yoshinori Makino, Noboru Yamamoto, Yuichiro Ohe, Akinobu Hamada
Topics & Concepts
PembrolizumabMedicinePopulationLung cancerInternal medicineOncologyPharmacokineticsGastroenterologyCancerImmunotherapyEnvironmental healthCancer Immunotherapy and BiomarkersRadiomics and Machine Learning in Medical ImagingInflammatory Biomarkers in Disease Prognosis